Literature DB >> 23188859

Idiopathic chylothorax in a young man.

Nayan Desai1, Udit Chaddha, Shivang Desai, Brian Gable.   

Abstract

Chylothorax refers to the presence of chyle in the pleural space owing to disruption or obstruction of the thoracic duct or one of its tributaries. We present a case of non-traumatic, idiopathic chylothorax in an 18-year-old man. Lymphoscintigraphy was used to identify the site of leak. We tried the full armamentarium of available non-surgical therapy on him, including a modified diet, chest tube insertion, total parenteral nutrition and octreotide. Yet, despite optimal medical therapy, his effusion continued to persist. He eventually required thoracic duct ligation, which resulted in resolution of the effusion.

Entities:  

Mesh:

Year:  2012        PMID: 23188859      PMCID: PMC4543965          DOI: 10.1136/bcr-2012-007318

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  [Surgery for chylothorax].

Authors:  M Riquet; A Badia
Journal:  Rev Pneumol Clin       Date:  2004-04

Review 2.  [Chylothorax].

Authors:  C Migliori; G Boroni; S Milianti; G Ekema
Journal:  Minerva Pediatr       Date:  2010-06       Impact factor: 1.312

Review 3.  A contemporary review of chylothorax.

Authors:  Arunabh Talwar; Hans J Lee
Journal:  Indian J Chest Dis Allied Sci       Date:  2008 Oct-Dec

Review 4.  Percutaneous treatment of thoracic duct injuries.

Authors:  Francesca Marcon; Katayun Irani; Theresa Aquino; John K Saunders; Thomas H Gouge; Marcovalerio Melis
Journal:  Surg Endosc       Date:  2011-05-17       Impact factor: 4.584

5.  Chylothorax and pseudochylothorax.

Authors:  C S Sassoon; R W Light
Journal:  Clin Chest Med       Date:  1985-03       Impact factor: 2.878

Review 6.  Octreotide and chylothorax.

Authors:  Ioannis Kalomenidis
Journal:  Curr Opin Pulm Med       Date:  2006-07       Impact factor: 3.155

7.  Pleural fluid characteristics of chylothorax.

Authors:  Fabien Maldonado; Finn J Hawkins; Craig E Daniels; Clinton H Doerr; Paul A Decker; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.